Guggenheim has initiated coverage on Bath & Body Works Inc (BBWI) with a Neutral rating. This marks the firm's first assessment of the retailer, which operates in the specialty retail sector and is renowned for its exclusive fragrances for both body and home.
Headquartered in Columbus, Ohio, Bath & Body Works employs approximately 8,975 full-time staff and operates over 1,890 company-operated locations in the U.S. and Canada, alongside more than 525 international franchised outlets. The company offers a diverse array of products, including fine fragrance mists, body lotions, 3-wick candles, and home fragrance diffusers.
As of December 9, 2025, Bath & Body Works is trading at $20.02, with a market capitalization of $3.0 billion. The company's price-to-earnings ratio stands at 4.35, and it has reported earnings per share of 3.27. The dividend yield is notably high at 514.1%.
Upcoming earnings are expected on May 19, 2026, with an estimated EPS of $0.31 and revenue of $1.4 billion. Recent earnings performance has shown mixed results, with the most recent quarter (Q3 2026) reporting an EPS of $0.35, falling short of the estimate of $0.40.
Analyst ratings serve as professional opinions based on extensive research and financial models. While such assessments can offer valuable insights, they are based on assumptions that may not always hold true. Investors should consider a multitude of factors, including company fundamentals and market trends, when making decisions. Analyst opinions can vary and are subject to change as new information becomes available.